Skip to content
healthcare.dev

levocetirizine dihydrochloride

NDC 11673-847, levocetirizine dihydrochloride, tablet, coated, from Target Corporation.

Product NDC
11673-847
Status
Listed
Labeler
Target Corporation
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA210375
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/11673-847 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVOCETIRIZINE DIHYDROCHLORIDE5 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
11673-847-16116730847162 BOTTLE in 1 CARTON (11673-847-16) / 80 TABLET, COATED in 1 BOTTLE
11673-847-35116730847351 BOTTLE in 1 CARTON (11673-847-35) / 35 TABLET, COATED in 1 BOTTLE
11673-847-80116730847801 BOTTLE in 1 CARTON (11673-847-80) / 80 TABLET, COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 11673-847 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/11673-847 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 11673-847. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.